Skip to main content
Fig. 1 | Genome Medicine

Fig. 1

From: A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research

Fig. 1

a Overview of the regulatory stakeholder relationship established between the Clinical Genome Resource (ClinGen) and the United States Food and Drug Administration (FDA). The two groups defined their common goals and developed transparent communications to seek insight and share progress. b Summary of the dynamics and benefits of partnering with community and regulatory stakeholders

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us